1Y Close · As of Aug 26, 2026
Access Bio operates in the Pharmaceuticals sector.
Legal name: Access Bio, Inc.
In fiscal year 2025, Access Bio (950130) reported revenue of 22 million KRW, down 73.3% from 82 million KRW a year earlier.
Operating profit was -45 million KRW and net income was -58 million KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 83.2 billion KRW, with a P/B of 213.73.
These figures can be verified in the DART filing (receipt no. 20260623000058).
Checks
2 of 8 checked items currently applicable.
Market Cap & Price: Market cap is above the delisting threshold.
Audit Opinion: Audit opinion: Unqualified (clean).
Convertible Bonds: No convertible bonds outstanding.
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: Treasury stock filings in the last 3 years: 1 cancellation(s).
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-14 | Semi-Annual Report (2026.06) |